Group One Trading
APYX icon

Group One Trading’s Apyx Medical APYX Stock Holding History

Group One Trading’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,444
Closed -$42.8K – 7585
2025
Q4 		$40.1K Buy
11,444
+9,652
+539% +$33.7K ﹤0.01% 5780
2025
Q3 		$3.83K Buy
+1,792
New +$3.79K ﹤0.01% 7664
2025
Q2 		– Sell
-810
Closed -$1.14K – 7903
2025
Q1 		$1.11K Sell
810
-1,583
-66% -$2.18K ﹤0.01% 7152
2024
Q4 		$3.78K Sell
2,393
-1,354
-36% -$1.89K ﹤0.01% 6529
2024
Q3 		$4.65K Hold
3,747
– – ﹤0.01% 5907
2024
Q2 		$5.02K Hold
3,747
– – ﹤0.01% 5954
2024
Q1 		$5.1K Hold
3,747
– – ﹤0.01% 6181
2023
Q4 		$9.82K Buy
3,747
+2,643
+239% +$6.4K ﹤0.01% 6215
2023
Q3 		$3.53K Buy
+1,104
New +$5.14K ﹤0.01% 6849
2019
Q1 		– Sell
-1,087
Closed -$8.41K – 4759
2018
Q4 		$7K Buy
+1,087
New +$6.58K ﹤0.01% 4376
2017
Q3 		– Sell
-8,400
Closed -$21K – 4783
2017
Q2 		$21K Buy
+8,400
New +$20.6K ﹤0.01% 3926

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Group One Trading's APYX Position: Q1 2026 in Review

Group One Trading sold out of Apyx Medical (APYX) in Q1 2026, closing a stake of 11,444 shares — an estimated $42.8K sold.

Group One Trading first reported a position in APYX in Q2 2017 and held it in 11 quarters. The position peaked at $40.1K in Q4 2025. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Group One Trading reported no remaining Apyx Medical position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 11,444 Apyx Medical shares in Q1 2026, an estimated $42.8K.
  • Group One Trading first reported a position in Apyx Medical in Q2 2017 and held it in 11 quarters.
  • Group One Trading's Apyx Medical position peaked at $40.1K in Q4 2025.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.